Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. (2022)
Attributed to:
DGEMBE: Developing GEnomic Medicine BEtween Africa and the UK
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12014-022-09345-1
PubMed Identifier: 35317720
Publication URI: http://europepmc.org/abstract/MED/35317720
Type: Journal Article/Review
Volume: 19
Parent Publication: Clinical proteomics
Issue: 1
ISSN: 1542-6416